Streetbeat News

Analyst Ratings

EXPD

Susquehanna analyst Bascome Majors maintains a Neutral rating on Expeditors Intl (NASDAQ:EXPD) and raises the price target from $104 to $115.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 5:09 pm

ATSG

Susquehanna analyst Christopher Stathoulopoulos maintains a positive outlook on Air Transport Services Group (ATSG) and raises the price target from $18 to $26.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 5:08 pm

VRDN

JMP Securities analyst Jason Butler maintains a Market Outperform rating on Viridian Therapeutics (NASDAQ:VRDN) but lowers the price target from $44 to $42.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 5:07 pm

SKWD

JMP Securities analyst Matthew Carletti maintains a Market Outperform rating on Skyward Specialty (NASDAQ:SKWD) and raises the price target from $30 to $32.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 5:06 pm

OB

JMP Securities analyst Andrew Boone maintains a Market Outperform rating on Outbrain (NASDAQ:OB) and raises the price target from $6 to $8.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 5:05 pm

LPRO

JMP Securities analyst David Scharf has maintained a Market Outperform rating on Open Lending (NASDAQ:LPRO), but lowered the price target from $12 to $11.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 5:04 pm

HIPO

JMP Securities analyst Matthew Carletti maintains a Market Outperform rating on Hippo Holdings (NYSE:HIPO) but has lowered the price target from $70 to $50.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 5:04 pm

CHX

ChampionX Corporation (CHX) was mentioned as a final trade on CNBC's Halftime Report.

Portfolio Pulse from Happy Mohamed

August 09, 2023 | 5:03 pm

GLBE

Analysts have provided various ratings for Global E Online (NASDAQ:GLBE) within the last quarter, with a majority leaning towards bullish. According to 16 analysts offering 12-month price targets in the last 3 months, Global E Online has an average price target of $45.06, which has increased by 13.36% over the past month.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 5:02 pm

CRNX

JMP Securities analyst Jonathan Wolleben maintains a Market Outperform rating on Crinetics Pharmaceuticals (NASDAQ:CRNX) but lowers the price target from $43 to $42.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 5:02 pm